Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,250
+250,000 vol $0.065 each |
1,890,000 | |
Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+1,200,000 vol $0.05 each |
||
Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$12,000
+120,000 vol $0.10 each |
164,791 | |
Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$120,000
+1,200,000 vol $0.10 each |
||
Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$6,000
+120,000 vol $0.05 each |
234,583 | |
Filed 2017-07-12 Tx date 2017-06-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
56 - Grant of rights
|
+25,000 vol |
25,000 | |
Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$375.00
+6,250 vol $0.06 each |
31,250 | |
Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,999
+83,333 vol $0.06 each |
114,583 | |
Filed 2017-07-12 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
57 - Exercise of rights
|
$-375.00
-25,000 vol $0.015 each |
0 | |
Filed 2017-07-12 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+3,125 vol |
3,125 | |
Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+41,666 vol |
44,791 | |
Filed 2017-02-09 Tx date 2017-02-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+25,000 vol $0.08 each |
25,000 | |
Filed 2017-02-09 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-07 Tx date 2017-02-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,640,000 | |
Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+140,000 vol |
640,000 | |
Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
500,000 | |
Filed 2015-06-02 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 |